Aspira Women’s Health (NYSE:AWH) Coverage Initiated by Analysts at

Stock analysts at began coverage on shares of Aspira Women’s Health (NYSE:AWHGet Rating) in a research report issued on Friday. The brokerage set a “sell” rating on the stock.

Aspira Women’s Health Price Performance

AWH stock opened at $0.35 on Friday. Aspira Women’s Health has a 12 month low of $0.32 and a 12 month high of $2.26.

Aspira Women’s Health Company Profile

(Get Rating)

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer.

Further Reading

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with's FREE daily email newsletter.